IR Contact 2cureX

Ole Thastrup, CSO 2cureX

The principle task of 2cureX´s Investor Relations is to provide investors and the capital market with accurate, relevant and timely information that facilitates an understanding of the operations of 2cureX.100

Contact Investor Relations for details:
Ole Thastrup, CSO 2cureX
Email: IR@2cureX.com
Telephone: +45 52115399

Kenneth Graabek Johansen, CFO 2cureX
Email: IR@2cureX.com
Telephone: +45 23490227

You are also welcome to ask your question or make your request by sending us an email.
Email: info@2cureX.com

Upcoming events

August 25, 2022

Interim Report Q2 2022 released

View previous reports

November 24, 2022

Interim Report Q3 2022 released

View previous reports

February 23, 2023

Year-End Report 2022 released

View previous reports

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.